High Molecular and Cytogenetic Risk in Myelofibrosis Does Not Benefit From Higher Intensity Conditioning Before Hematopoietic Cell Transplantation: An International Collaborative Analysis

There is no direct evidence to recommend specific conditioning intensities in myelofibrosis undergoing allogeneic hematopoietic cell transplantation, especially in the molecular era. We aimed to compare outcomes of reduced intensity (RIC) or myeloablative conditioning (MAC) transplantation in myelof...

Descripción completa

Detalles Bibliográficos
Autores principales: Gagelmann, Nico, Salit, Rachel B., Schroeder, Thomas, Badbaran, Anita, Rautenberg, Christina, Panagiota, Victoria, Wolschke, Christine, Thol, Felicitas, Cassinat, Bruno, Robin, Marie, Heuser, Michael, Reinhardt, Hans Christian, Scott, Bart L., Kröger, Nicolaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529040/
https://www.ncbi.nlm.nih.gov/pubmed/36204690
http://dx.doi.org/10.1097/HS9.0000000000000784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529040/
https://www.ncbi.nlm.nih.gov/pubmed/36204690
http://dx.doi.org/10.1097/HS9.0000000000000784

Ejemplares similares